A bill to require drug manufacturers to report certain information to this state; to provide for the powers and duties of certain state governmental officers and entities; to allow for the promulgation of rules; and to prescribe civil sanctions.
Requires drug manufacturers in Michigan to report detailed information about significant prescription drug price increases and new high-cost drugs, establishes public reporting and confidentiality provisions, and imposes civil penalties for non-compliance, with the aim of increasing transparency and oversight in drug pricing.
Introduced
by
Referred to the Committee on Health Policy
